Clinical Trial Update: A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. [Phase 1]

View source ↗

Summary

Phase Ib clinical trial of APG-115 as a single agent or in combination with azacitidine or cytarabine for acute myeloid leukemia or myelodysplastic syndromes; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• APG-115 (APG-115)
• AZACITIDINE (AZACITIDINE)
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) | Phase 1 | Status: RECRUITING